AKBA vs ULTA · rev $102.7M vs P/E 17, rev $3.04B
Akebia Ther (AKBA) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
AKBA currently screens at market cap $260.1M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the AKBA and ULTA stock pages for the full models.
Not investment advice.